Advanced Oncotherapy (LON:AVO) issued its earnings results on Monday. The company reported GBX (9.83) (($0.12)) earnings per share (EPS) for the quarter, missing the consensus estimate of GBX (8.90) (($0.11)) by GBX (0.93) (($0.01)), Bloomberg Earnings reports.
Shares of Advanced Oncotherapy stock opened at GBX 26 ($0.32) on Tuesday. The company has a debt-to-equity ratio of 55.71, a quick ratio of 0.79 and a current ratio of 2.16. The stock has a market capitalization of $79.66 million and a PE ratio of -1.86. Advanced Oncotherapy has a 52-week low of GBX 20 ($0.25) and a 52-week high of GBX 44.50 ($0.55). The company has a 50-day simple moving average of GBX 26.68 and a two-hundred day simple moving average of GBX 32.10.
About Advanced Oncotherapy
Read More: Are sell-side analysts objective?
Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.